Your browser doesn't support javascript.
loading
IL-24 is the key effector of Th9 cell-mediated tumor immunotherapy.
Chen, Jintong; Zhang, Yunwei; Zhang, Hua; Zhang, Mingyue; Dong, He; Qin, Tianxue; Gao, Sujun; Wang, Siqing.
Afiliación
  • Chen J; Department of Cancer Immunology, First Hospital of Jilin University, Changchun 130061, China.
  • Zhang Y; Department of Hematology, First Hospital of Jilin University, Changchun 130061, China.
  • Zhang H; Department of Gastrointestinal Surgery, First Hospital of Jilin University, Changchun 130021, China.
  • Zhang M; Department of Gynecological Oncology, First Hospital of Jilin University, Changchun 130021, China.
  • Dong H; Department of Gynecological Oncology, First Hospital of Jilin University, Changchun 130021, China.
  • Qin T; Department of Hematology, First Hospital of Jilin University, Changchun 130061, China.
  • Gao S; Department of Hematology, First Hospital of Jilin University, Changchun 130061, China.
  • Wang S; Department of Cancer Immunology, First Hospital of Jilin University, Changchun 130061, China.
iScience ; 26(9): 107531, 2023 Sep 15.
Article en En | MEDLINE | ID: mdl-37680459
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: IScience Año: 2023 Tipo del documento: Article País de afiliación: China
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: IScience Año: 2023 Tipo del documento: Article País de afiliación: China